{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:04:19Z","timestamp":1783955059966,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"DOI":"10.1007\/s00347-026-02472-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:07:22Z","timestamp":1783951642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapie chorioidaler Neovaskularisationen bei angioiden Streifen (AS) aufgrund von Pseudoxanthoma elasticum (PXE) und anderen Ursachen","Treatment of choroidal neovascularization associated with angioid streaks (AS) caused by pseudoxanthoma elasticum (PXE) and other causes"],"prefix":"10.1007","author":[{"name":"Deutsche Ophthalmologische Gesellschaft (DOG)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Charbel Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Claessens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Dysli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Feltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Retinologische Gesellschaft e.\u202fV. (RG)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Berufsverband der Augen\u00e4rztinnen und Augen\u00e4rzte Deutschlands e.\u202fV. (BVA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2472_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/J.PRETEYERES.2024.101274","volume":"102","author":"K Pfau","year":"2024","unstructured":"Pfau\u00a0K, Lengyel\u00a0I, Ossewaarde-van Norel\u00a0J et\u00a0al (2024) Pseudoxanthoma elasticum \u2013 Genetics, pathophysiology, and clinical presentation. Prog Retin Eye Res 102:101274. https:\/\/doi.org\/10.1016\/J.PRETEYERES.2024.101274","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"2472_CR2","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.survophthal.2008.12.006","volume":"54","author":"RP Finger","year":"2009","unstructured":"Finger\u00a0RP, Ladewig\u00a0C, Ladewig\u00a0MS et\u00a0al (2009) Pseudoxanthoma elasticum: genetics, clinical manifestations and therapeutic approaches. Surv Ophthalmol 54(2):272\u2013285. https:\/\/doi.org\/10.1016\/j.survophthal.2008.12.006","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"2472_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/J.EJMG.2018.05.020","volume":"62","author":"G Kranenburg","year":"2019","unstructured":"Kranenburg\u00a0G, Baas\u00a0AF, de Jong\u00a0PA, Asselbergs\u00a0FW, Visseren\u00a0FLJ, Spiering\u00a0W (2019) The prevalence of pseudoxanthoma elasticum: Revised estimations based on genotyping in a high vascular risk cohort. Eur J Med Genet 62(2):90\u201392. https:\/\/doi.org\/10.1016\/J.EJMG.2018.05.020","journal-title":"Eur J Med Genet"},{"issue":"7","key":"2472_CR4","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ophtha.2009.11.008","volume":"117","author":"P Charbel Issa","year":"2010","unstructured":"Charbel Issa\u00a0P, Finger\u00a0RP, Gotting\u00a0C et\u00a0al (2010) Centrifugal fundus abnormalities in pseudoxanthoma elasticum. Ophthalmol Sci 117(7):1406\u20131414. https:\/\/doi.org\/10.1016\/j.ophtha.2009.11.008","journal-title":"Ophthalmology"},{"key":"2472_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00014","volume":"4","author":"M Gliem","year":"2013","unstructured":"Gliem\u00a0M, Zaeytijd\u00a0JD, Finger\u00a0RP, Holz\u00a0FG, Leroy\u00a0BP, Charbel Issa\u00a0P (2013) An update on the ocular phenotype in patients with pseudoxanthoma elasticum. Front Genet 4:14. https:\/\/doi.org\/10.3389\/fgene.2013.00014","journal-title":"Front Genet"},{"issue":"2","key":"2472_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000310407","volume":"207","author":"AM Mansour","year":"1993","unstructured":"Mansour\u00a0AM, Ansari\u00a0NH, Shields\u00a0JA, Annesley\u00a0WH, Cronin\u00a0CM, Stock\u00a0EL (1993) Evolution of angioid streaks. Ophthalmologica 207(2):57\u201361. https:\/\/doi.org\/10.1159\/000310407","journal-title":"Ophthalmologica"},{"issue":"11","key":"2472_CR7","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/eye.2017.112","volume":"31","author":"A Marchese","year":"2017","unstructured":"Marchese\u00a0A, Parravano\u00a0M, Rabiolo\u00a0A et\u00a0al (2017) Optical coherence tomography analysis of evolution of Bruch\u2019s membrane features in angioid streaks. Eye (Lond) 31(11):1600\u20131605. https:\/\/doi.org\/10.1038\/eye.2017.112","journal-title":"Eye (Lond)"},{"key":"2472_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/JCM13123395","author":"K Raming","year":"2024","unstructured":"Raming\u00a0K, K\u00fcnzel\u00a0SH, Pfau\u00a0M, Hendig\u00a0D, Holz\u00a0FG, Pfau\u00a0K (2024) Optic Disc Drusen in Pseudoxanthoma Elasticum Are Associated with the Extent of Bruch\u2019s Membrane Calcification. J\u00a0Clin Med. https:\/\/doi.org\/10.3390\/JCM13123395","journal-title":"J Clin Med"},{"key":"2472_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJO.2024.03.026","author":"K Raming","year":"2024","unstructured":"Raming\u00a0K, Pfau\u00a0M, Herrmann\u00a0P, Holz\u00a0FG, Pfau\u00a0K (2024) Anti-VEGF treatment for secondary neovascularization in pseudoxanthoma elasticum - age of onset, treatment frequency and visual outcome. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/J.AJO.2024.03.026","journal-title":"Am J Ophthalmol"},{"key":"2472_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.4335","author":"K Hess","year":"2020","unstructured":"Hess\u00a0K, Gliem\u00a0M, Charbel Issa\u00a0P et\u00a0al (2020) Mesopic and Scotopic Light Sensitivity and Its Microstructural Correlates in Pseudoxanthoma Elasticum. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.4335","journal-title":"JAMA Ophthalmol"},{"key":"2472_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2021-320088","author":"K Hess","year":"2021","unstructured":"Hess\u00a0K, Raming\u00a0K, Charbel Issa\u00a0P, Herrmann\u00a0P, Holz\u00a0FG, Pfau\u00a0M (2021) Inner retinal degeneration associated with optic nerve head drusen in pseudoxanthoma elasticum. Br J Ophthalmol. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-320088","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2472_CR12","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1167\/IOVS.09-3541","volume":"50","author":"PC Issa","year":"2009","unstructured":"Issa\u00a0PC, Finger\u00a0RP, Holz\u00a0FG, Scholl\u00a0HPN (2009) Multimodal imaging including spectral domain OCT and confocal near infrared reflectance for characterization of outer retinal pathology in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 50(12):5913\u20135918. https:\/\/doi.org\/10.1167\/IOVS.09-3541","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2472_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAOPHTHALMOL.2025.4031","author":"J Meinke","year":"2025","unstructured":"Meinke\u00a0J, Raming\u00a0K, Kessler\u00a0C, Holz\u00a0FG, Pfau\u00a0M, Pfau\u00a0K (2025) High-Resolution Optical Coherence Tomography Correlates of Peau d\u2019Orange in Pseudoxanthoma Elasticum. JAMA Ophthalmol. https:\/\/doi.org\/10.1001\/JAMAOPHTHALMOL.2025.4031","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"2472_CR14","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1097\/IAE.0B013E3181AADE47","volume":"29","author":"RP Finger","year":"2009","unstructured":"Finger\u00a0RP, Issa\u00a0PC, Ladewig\u00a0M, G\u00f6tting\u00a0C, Holz\u00a0FG, Scholl\u00a0HPN (2009) Fundus autofluorescence in Pseudoxanthoma elasticum. Retina 29(10):1496\u20131505. https:\/\/doi.org\/10.1097\/IAE.0B013E3181AADE47","journal-title":"Retina"},{"issue":"8","key":"2472_CR15","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1097\/IAE.0000000000001744","volume":"38","author":"TYY Lai","year":"2018","unstructured":"Lai\u00a0TYY, Staurenghi\u00a0G, Lanzetta\u00a0P et\u00a0al (2018) Efficacy And Safety Of Ranibizumab For The Treatment Of Choroidal Neovascularization Due To Uncommon Cause: Twelve-Month Results of the MINERVA Study. Retina 38(8):1464\u20131477. https:\/\/doi.org\/10.1097\/IAE.0000000000001744","journal-title":"Retina"},{"issue":"4","key":"2472_CR16","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/J.AJO.2011.03.022","volume":"152","author":"RP Finger","year":"2011","unstructured":"Finger\u00a0RP, Charbel Issa\u00a0P, Hendig\u00a0D, Scholl\u00a0HPN, Holz\u00a0FG (2011) Monthly ranibizumab for choroidal neovascularizations secondary to angioid streaks in pseudoxanthoma elasticum: a\u00a0one-year prospective study. Am J Ophthalmol 152(4):695\u2013703. https:\/\/doi.org\/10.1016\/J.AJO.2011.03.022","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"2472_CR17","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1038\/EYE.2009.158","volume":"23","author":"S Kang","year":"2009","unstructured":"Kang\u00a0S, Roh\u00a0YJ (2009) Intravitreal ranibizumab for choroidal neovascularisation secondary to angioid streaks. Eye (Lond) 23(8):1750\u20131751. https:\/\/doi.org\/10.1038\/EYE.2009.158","journal-title":"Eye (Lond)"},{"issue":"8","key":"2472_CR18","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/IAE.0B013E3181D2F11D","volume":"30","author":"ID Ladas","year":"2010","unstructured":"Ladas\u00a0ID, Kotsolis\u00a0AI, Ladas\u00a0DS et\u00a0al (2010) Intravitreal ranibizumab treatment of macular choroidal neovascularization secondary to angioid streaks: one-year results of a prospective study. Retina 30(8):1185\u20131189. https:\/\/doi.org\/10.1097\/IAE.0B013E3181D2F11D","journal-title":"Retina"},{"key":"2472_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/J.1755-3768.2009.01813.X","author":"SB Bloch","year":"2011","unstructured":"Bloch\u00a0SB, Larsen\u00a0M (2011) Fibrosis of extramacular angioid streaks following ranibizumab treatment of subfoveal choroidal neovascularization. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/J.1755-3768.2009.01813.X","journal-title":"Acta Ophthalmol"},{"key":"2472_CR20","doi-asserted-by":"publisher","DOI":"10.1111\/J.1755-3768.2009.01754.X","author":"K Lazaros","year":"2010","unstructured":"Lazaros\u00a0K, Leonidas\u00a0Z (2010) Intravitreal ranibizumab as primary treatment for neovascular membrane associated with angioid streaks. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/J.1755-3768.2009.01754.X","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"2472_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/EYE.2012.116","volume":"26","author":"M Shah","year":"2012","unstructured":"Shah\u00a0M, Amoaku\u00a0WMK (2012) Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks. Eye (Lond) 26(9):1194\u20131198. https:\/\/doi.org\/10.1038\/EYE.2012.116","journal-title":"Eye (Lond)"},{"issue":"3","key":"2472_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/IAE.0000000000000745","volume":"36","author":"J Tilleul","year":"2016","unstructured":"Tilleul\u00a0J, Mimoun\u00a0G, Querques\u00a0G et\u00a0al (2016) Intravitreal ranibizumab for choroidal neovascularization in angioid streaks: Four-year follow-up. Retina 36(3):483\u2013491. https:\/\/doi.org\/10.1097\/IAE.0000000000000745","journal-title":"Retina"},{"key":"2472_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJO.2009.04.026","author":"M Sawa","year":"2009","unstructured":"Sawa\u00a0M, Gomi\u00a0F, Tsujikawa\u00a0M, Sakaguchi\u00a0H, Tano\u00a0Y (2009) Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Am J Ophthalmol. https:\/\/doi.org\/10.1016\/J.AJO.2009.04.026","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"2472_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/J.1600-0420.2006.00762.X","volume":"84","author":"A Teixeira","year":"2006","unstructured":"Teixeira\u00a0A, Moraes\u00a0N, Farah\u00a0ME, Bonomo\u00a0PP (2006) Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks. Acta Ophthalmol Scand 84(6):835\u2013836. https:\/\/doi.org\/10.1111\/J.1600-0420.2006.00762.X","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"2472_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1136\/BJO.2007.129916","volume":"92","author":"RP Finger","year":"2008","unstructured":"Finger\u00a0RP, Ladewig\u00a0CI, Holz\u00a0M, Scholl\u00a0FG, Scholl\u00a0HPN (2008) Intravitreal bevacizumab for choroidal neovascularisation associated with pseudoxanthoma elasticum. Br J Ophthalmol 92(4):483\u2013487. https:\/\/doi.org\/10.1136\/BJO.2007.129916","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2472_CR26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5301\/EJO.5000505","volume":"25","author":"C Rosina","year":"2015","unstructured":"Rosina\u00a0C, Romano\u00a0M, Cigada\u00a0M, de Polo\u00a0L, Staurenghi\u00a0G, Bottoni\u00a0F (2015) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study. Eur J Ophthalmol 25(1):47\u201350. https:\/\/doi.org\/10.5301\/EJO.5000505","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"2472_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1755-3768.2009.01836.x","volume":"89","author":"L El Matri","year":"2011","unstructured":"El Matri\u00a0L, Kort\u00a0F, Bouraoui\u00a0R, Karim\u00a0B, Chebil\u00a0A, Chaker\u00a0N (2011) Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: One year of follow-up. Acta Ophthalmol 89(7):641\u2013646. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01836.x","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"2472_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/S00417-019-04551-4","volume":"258","author":"M Gliem","year":"2020","unstructured":"Gliem\u00a0M, Birtel\u00a0J, Herrmann\u00a0P et\u00a0al (2020) Aflibercept for choroidal neovascularizations secondary to pseudoxanthoma elasticum: a prospective study. Graefes Arch Clin Exp Ophthalmol 258(2):311\u2013318. https:\/\/doi.org\/10.1007\/S00417-019-04551-4","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"2472_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/1120672119838133","volume":"30","author":"R Sekfali","year":"2020","unstructured":"Sekfali\u00a0R, Mimoun\u00a0G, Cohen\u00a0SY et\u00a0al (2020) Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks. Eur J Ophthalmol 30(3):550\u2013556. https:\/\/doi.org\/10.1177\/1120672119838133","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"2472_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4103\/0301-4738.167121","volume":"63","author":"E Esen","year":"2015","unstructured":"Esen\u00a0E, Sizmaz\u00a0S, Demircan\u00a0N (2015) Intravitreal aflibercept for management of subfoveal choroidal neovascularization secondary to angioid streaks. Indian J Ophthalmol 63(7):616\u2013618. https:\/\/doi.org\/10.4103\/0301-4738.167121","journal-title":"Indian J Ophthalmol"},{"key":"2472_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/3442306","volume":"2022","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty\u00a0S, Sheth\u00a0JU (2022) Intravitreal Brolucizumab for Choroidal Neovascularization Associated to Angioid Streaks. Case Rep Ophthalmol Med 2022:1\u20134. https:\/\/doi.org\/10.1155\/2022\/3442306","journal-title":"Case Rep Ophthalmol Med"},{"key":"2472_CR32","doi-asserted-by":"publisher","unstructured":"Das M, Sharmin S (2026) Open Access Journal of Ophthalmology Committed to Create Value for Researchers Angioid Streaks with Macular Neovascularization: Clinical Insights from Two Cases. J Ophthalmolhttps:\/\/doi.org\/10.23880\/oajo-16000347","DOI":"10.23880\/oajo-16000347"},{"issue":"10","key":"2472_CR33","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1001\/jamaophthalmol.2019.2910","volume":"137","author":"M Gliem","year":"2019","unstructured":"Gliem\u00a0M, Birtel\u00a0J, M\u00fcller\u00a0PL et\u00a0al (2019) Acute Retinopathy in Pseudoxanthoma Elasticum. JAMA Ophthalmol 137(10):1165\u20131173. https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.2910","journal-title":"JAMA Ophthalmol"},{"key":"2472_CR34","doi-asserted-by":"publisher","DOI":"10.1167\/IOVS.66.11.25","author":"K Raming","year":"2025","unstructured":"Raming\u00a0K, Saltenberger\u00a0I, Meinke\u00a0J et\u00a0al (2025) Intraocular Pressure After Anti-Vascular Endothelial Growth Factor Injection in Eyes With a\u00a0Mineralized Bruch\u2019s Membrane Caused by Pseudoxanthoma Elasticum. Invest Ophthalmol Vis Sci. https:\/\/doi.org\/10.1167\/IOVS.66.11.25","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10326","key":"2472_CR35","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"JS Heier","year":"2022","unstructured":"Heier\u00a0JS, Khanani\u00a0AM, Quezada Ruiz\u00a0C et\u00a0al (2022) Efficacy, durability, and safety of intravitreal faricimab up to every 16\u00a0weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase\u00a03, non-inferiority trials. Lancet 399(10326):729\u2013740. https:\/\/doi.org\/10.1016\/S0140-6736(22)00010-1","journal-title":"Lancet"},{"key":"2472_CR36","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251395518","author":"R Fasana","year":"2025","unstructured":"Fasana\u00a0R, Eriksen\u00a0NS, Borrelli\u00a0E, Pfau\u00a0K, Subhi\u00a0Y (2025) Intravitreal faricimab treatment for traumatic choroidal rupture and macular neovascularization in angioid streaks: A\u00a0case report. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721251395518","journal-title":"Eur J Ophthalmol"},{"key":"2472_CR37","unstructured":"In Japanese Study, Vabysmo Achieves Primary Endpoint in Phase\u00a03\u00a0Study for Angioid Streaks - Modern Optometry. Accessed February\u00a09, 2026. https:\/\/modernod.com\/news\/in-japanese-study-vabysmo-achieves-primary-endpoint-in-phase-3-study-for-angioid-streaks\/2482231\/"},{"key":"2472_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2010.06.004","author":"G Mimoun","year":"2010","unstructured":"Mimoun\u00a0G, Tilleul\u00a0J, Leys\u00a0A, Coscas\u00a0G, Soubrane\u00a0G, Souied\u00a0EH (2010) Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. AJO Int. https:\/\/doi.org\/10.1016\/j.ajo.2010.06.004","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2472_CR39","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/EYE.2015.283","volume":"30","author":"T Diago","year":"2016","unstructured":"Diago\u00a0T (2016) Treat and extend regimen with aflibercept for choroidal neovascularization in angioid streaks. Eye (Lond) 30(4):637\u2013639. https:\/\/doi.org\/10.1038\/EYE.2015.283","journal-title":"Eye (Lond)"},{"issue":"4","key":"2472_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S0161-6420(99)90167-7","volume":"106","author":"PT Merrill","year":"1999","unstructured":"Merrill\u00a0PT, LoRusso\u00a0FJ, Lomeo\u00a0MD, Saxe\u00a0SJ, Khan\u00a0MM, Lambert\u00a0HM (1999) Surgical removal of subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology 106(4):782\u2013789. https:\/\/doi.org\/10.1016\/S0161-6420(99)90167-7","journal-title":"Ophthalmology"},{"issue":"4","key":"2472_CR41","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/00006982-200108000-00004","volume":"21","author":"ES Lit","year":"2001","unstructured":"Lit\u00a0ES, Kim\u00a0RY, D\u2019Amico\u00a0DJ (2001) Surgical removal of subfoveal choroidal neovascularization without removal of posterior hyaloid: a\u00a0consecutive series in younger patients. Retina 21(4):317\u2013323. https:\/\/doi.org\/10.1097\/00006982-200108000-00004","journal-title":"Retina"},{"issue":"8","key":"2472_CR42","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/S0161-6420(94)31172-9","volume":"101","author":"MA Thomas","year":"1994","unstructured":"Thomas\u00a0MA, Dickinson\u00a0JD, Melberg\u00a0NS, Ibanez\u00a0HE, Dhaliwal\u00a0RS (1994) Visual results after surgical removal of subfoveal choroidal neovascular membranes. Ophthalmology 101(8):1384\u20131396. https:\/\/doi.org\/10.1016\/S0161-6420(94)31172-9","journal-title":"Ophthalmology"},{"issue":"3","key":"2472_CR43","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0002-9394(00)00809-6","volume":"131","author":"DB Roth","year":"2001","unstructured":"Roth\u00a0DB, Estafanous\u00a0M, Lewis\u00a0H (2001) Macular translocation for subfoveal choroidal neovascularization in angioid streaks. Am J Ophthalmol 131(3):390\u2013392. https:\/\/doi.org\/10.1016\/S0002-9394(00)00809-6","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"2472_CR44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0002-9394(14)71398-4","volume":"116","author":"JI Lim","year":"1993","unstructured":"Lim\u00a0JI, Bressler\u00a0NM, Marsh\u00a0MJ, Bressler\u00a0SB (1993) Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 116(4):414\u2013423. https:\/\/doi.org\/10.1016\/S0002-9394(14)71398-4","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"2472_CR45","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/00006982-200410000-00013","volume":"24","author":"U Menchini","year":"2004","unstructured":"Menchini\u00a0U, Virgili\u00a0G, Introini\u00a0U et\u00a0al (2004) Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina 24(5):763\u2013771. https:\/\/doi.org\/10.1097\/00006982-200410000-00013","journal-title":"Retina"},{"issue":"7","key":"2472_CR46","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1097\/IAE.0b013e3182914d2b","volume":"33","author":"M Gliem","year":"2013","unstructured":"Gliem\u00a0M, Finger\u00a0RP, Fimmers\u00a0R, Brinkmann\u00a0CK, Holz\u00a0FG, Charbel Issa\u00a0P (2013) Treatment of choroidal neovascularization due to angioid streaks: a comprehensive review. Retina 33(7):1300\u20131314. https:\/\/doi.org\/10.1097\/IAE.0b013e3182914d2b","journal-title":"Retina"},{"issue":"7","key":"2472_CR47","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1001\/ARCHOPHT.126.7.941","volume":"126","author":"LK Chang","year":"2008","unstructured":"Chang\u00a0LK, Spaide\u00a0RF, Brue\u00a0C, Freund\u00a0KB, Klancnik\u00a0JM, Slakter\u00a0JS (2008) Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Arch Ophthalmol 126(7):941\u2013945. https:\/\/doi.org\/10.1001\/ARCHOPHT.126.7.941","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"2472_CR48","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1097\/IAE.0B013E318207D1DC","volume":"31","author":"RP Finger","year":"2011","unstructured":"Finger\u00a0RP, Issa\u00a0PC, Schmitz-Valckenberg\u00a0S, Holz\u00a0FG, Scholl\u00a0HN (2011) Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Retina 31(7):1268\u20131278. https:\/\/doi.org\/10.1097\/IAE.0B013E318207D1DC","journal-title":"Retina"},{"key":"2472_CR49","doi-asserted-by":"publisher","unstructured":"Bhatnagar P, Freund KB, Spaide RF, et\u00a0al (2007) Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 27(7):897\u2013902. https:\/\/doi.org\/10.1097\/IAE.0B013E31809FF5DF","DOI":"10.1097\/IAE.0B013E31809FF5DF"},{"issue":"5","key":"2472_CR50","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/J.1600-0420.2007.00895.X","volume":"85","author":"R Pedersen","year":"2007","unstructured":"Pedersen\u00a0R, Soliman\u00a0W, Lund-Andersen\u00a0H, Larsen\u00a0M (2007) Treatment of choroidal neovascularization using intravitreal bevacizumab. Acta Ophthalmol Scand 85(5):526\u2013533. https:\/\/doi.org\/10.1111\/J.1600-0420.2007.00895.X","journal-title":"Acta Ophthalmol Scand"},{"issue":"4","key":"2472_CR51","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1055\/S-0029-1245256","volume":"227","author":"L Hefner","year":"2010","unstructured":"Hefner\u00a0L, Riese\u00a0J, Gerding\u00a0H (2010) Treatment of a choroidal neovascular membrane in angioid streaks with ranibizumab. Klin Monbl Augenheilkd 227(4):351\u2013352. https:\/\/doi.org\/10.1055\/S-0029-1245256","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"2472_CR52","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/IAE.0B013E3181CAFC75","volume":"30","author":"M Vadal\u00e0","year":"2010","unstructured":"Vadal\u00e0\u00a0M, Pece\u00a0A, Cipolla\u00a0S et\u00a0al (2010) Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab. Retina 30(6):903\u2013907. https:\/\/doi.org\/10.1097\/IAE.0B013E3181CAFC75","journal-title":"Retina"},{"issue":"3","key":"2472_CR53","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/00006982-199515030-00003","volume":"15","author":"DA Adelberg","year":"1995","unstructured":"Adelberg\u00a0DA, Del Priore\u00a0LV, Kaplan\u00a0HJ (1995) Surgery for subfoveal membranes in myopia, angioid streaks, and other disorders. Retina 15(3):198\u2013205. https:\/\/doi.org\/10.1097\/00006982-199515030-00003","journal-title":"Retina"},{"issue":"1","key":"2472_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00006982-199701000-00003","volume":"17","author":"A Pece","year":"1997","unstructured":"Pece\u00a0A, Avanza\u00a0P, Galli\u00a0L, Brancato\u00a0R (1997) Laser photocoagulation of choroidal neovascularization in angioid streaks. Retina 17(1):12\u201316. https:\/\/doi.org\/10.1097\/00006982-199701000-00003","journal-title":"Retina"},{"issue":"4","key":"2472_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1136\/BJO.77.4.218","volume":"77","author":"MW Ulbig","year":"1993","unstructured":"Ulbig\u00a0MW, McHugh\u00a0DA, Hamilton\u00a0AMP (1993) Photocoagulation of choroidal neovascular membranes with a diode laser. Br J Ophthalmol 77(4):218\u2013221. https:\/\/doi.org\/10.1136\/BJO.77.4.218","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"2472_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0002-9394(88)90014-1","volume":"105","author":"\u00d6 Gelisken","year":"1988","unstructured":"Gelisken \u00d6, Hendrikse\u00a0F, Deutman\u00a0AF (1988) A long-term follow-up study of laser coagulation of neovascular membranes in angioid streaks. Am J Ophthalmol 105(3):299\u2013303. https:\/\/doi.org\/10.1016\/0002-9394(88)90014-1","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"2472_CR57","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/s00417-005-1193-y","volume":"243","author":"H Heimann","year":"2005","unstructured":"Heimann\u00a0H, Gelisken\u00a0F, Wachtlin\u00a0J et\u00a0al (2005) Photodynamic therapy with verteporfin for choroidal neovascularisation associated with angioid streaks. Graefes Arch Clin Exp Ophthalmol 243(11):1115\u20131123. https:\/\/doi.org\/10.1007\/s00417-005-1193-y","journal-title":"Graefe\u2019s Archive for Clinical and Experimental Ophthalmology"},{"issue":"5","key":"2472_CR58","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/SJ.EYE.6701930","volume":"20","author":"AKK Chung","year":"2006","unstructured":"Chung\u00a0AKK, Gauba\u00a0V, Ghanchi\u00a0FD (2006) Photodynamic therapy (PDT) using verteporfin for juxtafoveal choroidal neovascularisation (CNV) in angioid streaks (AS) associated with pseudoxanthoma elasticum: 40\u00a0months results. Eye (Lond) 20(5):629\u2013631. https:\/\/doi.org\/10.1038\/SJ.EYE.6701930","journal-title":"Eye (Lond)"},{"issue":"6","key":"2472_CR59","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/S00417-005-0131-3","volume":"244","author":"L Arias","year":"2006","unstructured":"Arias\u00a0L, Pujol\u00a0O, Rubio\u00a0M, Caminal\u00a0J (2006) Long-term results of photodynamic therapy for the treatment of choroidal neovascularization secondary to angioid streaks. Graefes Arch Clin Exp Ophthalmol 244(6):753\u2013757. https:\/\/doi.org\/10.1007\/S00417-005-0131-3","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"2472_CR60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/112067210501500111","volume":"15","author":"ID Ladas","year":"2005","unstructured":"Ladas\u00a0ID, Georgalas\u00a0I, Rouvas\u00a0AA, Gotsis\u00a0S, Karagiannis\u00a0DA, Moschos\u00a0M (2005) Photodynamic therapy with verteporfin of choroidal neovascularization in angioid streaks: conventional versus early retreatment. Eur J Ophthalmol 15(1):69\u201373. https:\/\/doi.org\/10.1177\/112067210501500111","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"2472_CR61","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2147\/OPTH.S10649","volume":"4","author":"A Pece","year":"2010","unstructured":"Pece\u00a0A, Russo\u00a0G, Ricci\u00a0F, Isola\u00a0V, Introini\u00a0U, Querques\u00a0G (2010) Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks. Clin Ophthalmol 4(1):525\u2013530. https:\/\/doi.org\/10.2147\/OPTH.S10649","journal-title":"Clin Ophthalmol"},{"key":"2472_CR62","doi-asserted-by":"publisher","unstructured":"Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D (2017) Intraokulare Injektion von Bevacizumab - Eine m\u00f6gliche Therapie der sekund\u00e4ren CNV bei angioid streaks [Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks]. Ophthalmologe 104(4):325-8 https:\/\/doi.org\/10.1007\/s00347-006-1456-y","DOI":"10.1007\/s00347-006-1456-y"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-026-02472-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-026-02472-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:07:23Z","timestamp":1783951643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-026-02472-2"}},"subtitle":["Stellungnahme der Deutschen Ophthalmologischen Gesellschaft (DOG), der Retinologischen Gesellschaft (RG) und des Berufsverbands der Augen\u00e4rztinnen und Augen\u00e4rzte Deutschlands (BVA). Stand 22.04.2026","Statement of the German Society of Ophthalmology (DOG), the German Retina Society (RG) and the German Professional Association of Ophthalmologists (BVA). Status: 22 April 2026"],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":62,"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1007\/s00347-026-02472-2","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"11 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Siehe Tab.\u00a0\n                      \n                      im Anhang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}